(Q26781285)

English

Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis (English)

0 references

0 references

Aaron E Miller

1

0 references

language of work or name

English

0 references

publication date

1 October 2015

0 references

published in

Clinical Therapeutics

0 references

volume

37

0 references

issue

10

0 references

page(s)

2366-80

0 references

1 reference

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Teriflunomide and its mechanism of action in multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of multiple sclerosis and the place of teriflunomide

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Teriflunomide in relapsing multiple sclerosis: therapeutic utility

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.CLINTHERA.2015.08.003

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.CLINTHERA.2015.08.003

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3017337

OpenCitations bibliographic resource ID

3017337

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3017337

(Q26781285)

Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)